Patients with cancer present clinical cytokine patterns that suggest that simultaneous immunostimulation and immunosuppression occur in patients with cancer, with increased concentrations of the cytokines like TNFα, interleukin 6, interleukin 8, interleukin 10, and interleukin 18 [19]. Here, IL6 is linked to cancer.